Search form

Sections

AstraZeneca

The Markingson Files: University of Minnesota under new scrutiny in drug trial death

Dan Markingson suffered from schizophrenia and killed himself in May 2004 while taking part in a clinical trial for an antipsychotic drug made by AstraZeneca. The evolving case continues to highlight problems of research oversight at the university and state levels.

The American Heart Association--Protecting Industry Not Patients by Barbara Roberts, MD, and Martha Rosenberg

The American Heart Association (AHA) and the American College of Cardiology (ACC) recently released new cardiovascular disease prevention guidelines. They are an egregious example of much that is wrong with medicine today.

Will Risperdal Settlement Change Anything?

Many say the only justice that will get Big Pharma's attention is frog marching the CEOs off to prison and/or cutting them off from their lucrative public trough of Medicare, Medicaid and military health programs.

Doctors report big pharma payouts for drug endorsements

The makers of popular drugs like Advair, Cymbalta, Viagra and Zoloft have physicians, psychiatrists, and medical school faculty members across California on their payrolls. Does this influence prescribing patterns?

Top Prescribers: How One Doctor Made Medi-Cal's Psychiatric Drug List

How does a doctor become a top prescriber of a psychiatric drug in one state’s Medicaid program? A "stunned" California psychiatrist tries to figure out why.

It's Complicated: Taking Conflict of Interest Beyond Pharma Payments to Researchers

I wrote a piece recently for Health News Review about conflicts of interest. The original post is below, followed by more great examples of writers describing unexpected conflicts in detail.

The Markingson Files: Court leaves key questions in clinical trial suicide unanswered

Any investigative reporter will tell you that a case dismissal does not necessarily mean a victory. Here's how that rule of thumb figures into the case of Dan Markingson, who committed suicide after participating in a clinical trial for the psychiatric drug Seroquel.

The Markingson Files: Conflicts of interest in clinical trials should be transparent

It can be uncomfortable asking people about their finances. In journalism, though, there is an obligation not only to ask, but to ask for proof — especially with clinical trials.

The Markingson Files: Why health writers should track the money behind medical studies

One of the biggest oversights a health writer can make is to cover a scientific study and not talk about its funders. William Heisel examines what can happen when a study's funding is overlooked.

Pages

Announcements

Since the passage of the ACA, hospital consolidation has dramatically increased. Our webinar will give an overview of this trend, clarify what’s at stake for consumers, and give journalists fresh ideas for reporting in new, incisive ways. Our panel will include experts Martin Gaynor and Paul Ginsburg, as well as NYT’s Margot Sanger-Katz. More info here.

Reporting on Health invites fellows and friends who are attending the AHCJ conference to join us for drinks and appetizers from 6:30-8 p.m. April 24 at Pedro's Restaurant & Cantina, 3935 Freedom Circle, Santa Clara.  We'll buy a drink for the first 30 folks who arrive and provide appetizers for all. RSVP here.

CONNECT WITH THE COMMUNITY

Member Activities

Scott Kahan's profile has been updated

Connect with Scott Kahan

William Heisel has shared a blog post

Read it.

Ryan White's profile has been updated

Connect with Ryan White

Eulimar Nunez joined the community

Connect with Eulimar Nunez

Anna Romano has shared a blog post

Read it.
More Member Activities

Follow Us

ReportingHealth

Reporting on Underserved Communities



How can journalists and foundations collaborate to deepen and improve reporting on underserved communities? Our USC Annenberg School of Journalism program in collaboration with The California Endowment, the Wyncote Foundation and Media Impact Funders, convened 75 leaders from both fields.

Read More »